MedTrace Logo

Ridge Preservation Using Xenogenic Bone Graft and Pre-hydrated Collagen Membrane

NCT04955873 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2021-08-10

No results posted yet for this study

Summary

This pilot multicentric randomized controlled clinical trial is aimed at evaluating the composition of the new-formed tissue into the dental socket after 6 months from tooth extraction and the application of a combination of xenograft bone granules and collagen membrane. Extraction sites will be either grafted with Dentsply Symbios Xenograft Granules and covered with Dentsply Symbios pre-hydrated Collagen Resorbable Membrane or grafted with Geistlich Bio-Oss Collagen and covered with Geistlich Bio-Gide membrane. Results will be compared to spontaneous socket healing.

Conditions

  • Alveolar Bone Resorption
  • Edentulous Alveolar Ridge

Interventions

DEVICE

Treatment of the dental extraction socket using newly-released biomaterials

Treatment of the dental extraction socket with the combined use with the combined use of a newly-released xenogenic bone granules and a resorbable collagen membrane.

DEVICE

Treatment of the dental extraction socket using well-known biomaterials

Treatment of the dental extraction socket with the combined use of a well-known xenogenic bone granules and a resorbable collagen membrane

Sponsors & Collaborators

  • Dentsply Sirona Implants and Consumables

    collaborator INDUSTRY

  • Fondazione Bruno Kessler

    lead OTHER

Principal Investigators

  • Francesco Tessarolo, PhD · Bruno Kessler Fundation, Trento Italy

  • Paolo Ghensi, DDS, PhD · Università degli Studi di Trento

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-31
Primary Completion
2023-02-01
Completion
2023-04-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04955873 on ClinicalTrials.gov